Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
The companies will work with investigators to share the results with the scientific community
The companies will work with investigators to share the results with the scientific community
Subscribe To Our Newsletter & Stay Updated